Atlas Trials

PYC Therapeutics

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch PYC Therapeutics

RecordFirmDate
Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy (Myrtle) (NCT06970106)PYC Therapeutics2025-09-30
A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 (NCT06852963)PYC Therapeutics2025-06-01
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003 (NCT06714006)PYC Therapeutics2025-04-07
SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew) (NCT06461286)PYC Therapeutics2024-10-31
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) (NCT06455826)PYC Therapeutics2024-06-13
Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation (NCT06140329)PYC Therapeutics2024-02-28
SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (NCT05902962)PYC Therapeutics2023-04-20
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy (NCT05573984)PYC Therapeutics2022-07-07

Track PYC Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.